《大行報告》野村下調中國平安(02318.HK)目標價至85.56元 評級「買入」
野村指中國平安(02318.HK)2021年淨息差收窄,按季收窄3個基點,按年收窄9個基點至2.79%,而季度淨息差進一步縮小,由第三季2.75%降至第四季2.74%,預期平安2022年及2023年淨息差將縮至2.77%,相對2021年為2.79%。
野村稱,平安的貸款撥備按年增長37.7%至594億元人民幣,認為平安可能會繼續建立其不良貸款緩衝區,尤其與房地產相關方面,故野村將平安2022年預測信貸撥備提高3%。
野村將平安2021年及2022年稅後營運溢利分別下調1.2%及1.7%,純利分別調低11%,該行將平安目標價由87.75元調低至85.56元,評級「買入」。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.